As the industry advances closer and closer towards implementing the provisions of the Drug Supply Chain Security Act (DSCSA), is your company on track? With the deadline for serialization come and gone, what’s next? Cardinal Health 3PL Services recently compiled a white paper diving into the details of DSCSA compliance and looking forward to what’s next.
In this whitepaper, we provide guidance on where drug manufacturers should be in the compliance process, discuss the major challenges they are likely to face when working to comply with the first phases of the law, and explore some of the best practices we’ve identified as Cardinal Health 3PL Services has partnered to help pharmaceutical companies reach full DSCSA compliance by 2023.
Be sure to share this overview with colleagues to offer a primer on DSCSA regulations and the priority they should take within your organization. Check out the content to evaluate your own plans against industry peers.
2023, the ﬁnal deadline for full DSCSA implementation, may seem a long way oﬀ. But the deadlines for each phase will arrive quickly. Cardinal Health 3PL Services can help your company fulﬁll DSCSA requirements by expertly facilitating key components of your serialization strategy, including:
- Inbound scanning
- 2-D barcode testing
- Electronic TI/TH/TS transmission via EDI or web-based portal
- Data storage
- Identification and verification of serialized product returns intended for resale
- Reporting for your serialization data
- Verification of serialized product throughout the supply chain, within 24 hours
Additionally, this year we’ll be able to provide access to serialized data to downstream customers facilitating the capture and transmission of outbound EPCIS information and providing support for the Verification Router Service (VRS).
Regardless of whether you are already on track with the preliminary requirements, or need assistance putting a serialization program in place, we can ensure you are ready for 2023. Contact your CRM to learn more and read the whitepaper for more details.